About
Cavos Biotech is an emerging genomic and data science company focused on discovering and developing novel therapeutics. They leverage a multi-level genomic algorithm to uncover the genetic basis of extraordinary cancer resistance, aiming to create new drugs for various diseases.
Listed competitors
Also in this space
AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
Shares Life Sciences, Biotech
AI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Shares Life Sciences, Drug Discovery
Computational platform using LLMs trained on biological and chemical data for drug discovery.
Shares Life Sciences, Drug Discovery
AI-driven platform for protein-level disease mapping and drug discovery.
Shares Life Sciences, Drug Discovery
AI-powered blood test for early cancer detection and subtyping.
Shares Life Sciences, Biotech
Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.
Shares Life Sciences, Genomics
Key facts
At-a-glance profile data
- Website
- cavosbiotech.com
- Headquarters
- Cambridge, United States
- Founded
- 2021
- Employees
- 9
- Total funding
- -
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jun 2024 | Seed | Undisclosed | - |
Frequently asked
How many employees does Cavos Biotech have?
Cavos Biotech has approximately 9 people on record.
What is Cavos Biotech's current status?
Cavos Biotech's current operating status is: Inactive.
